CO6251209A2 - Esteres ciclicos de boro y composiciones que los contienen - Google Patents
Esteres ciclicos de boro y composiciones que los contienenInfo
- Publication number
- CO6251209A2 CO6251209A2 CO09145296A CO09145296A CO6251209A2 CO 6251209 A2 CO6251209 A2 CO 6251209A2 CO 09145296 A CO09145296 A CO 09145296A CO 09145296 A CO09145296 A CO 09145296A CO 6251209 A2 CO6251209 A2 CO 6251209A2
- Authority
- CO
- Colombia
- Prior art keywords
- proviso
- unsubstituted
- substituted
- compositions containing
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic System
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Esta invención proporciona, entre otras cosas, compuestos novedosos útiles para tratar infecciones bacterianas, composiciones farmacéuticas que contienen tales compuestos, así como combinaciones de estos compuestos con al menos un agente terapéuticamente eficaz adicional. 1.- Un compuesto que tiene una estructura según la fórmula:en la que R* es seleccionado de H y una carga negativa; R3 es seleccionado de H, ciano, nitroalquilo sustituido o no sustituido y aminoalquilo sustituido o no sustituido; Ra es seleccionado de H o -YR5 en el que Y es seleccionado de O y S; R5 es seleccionado de H, alquilo sustituido o no sustituido y heteroalquilo sustituido o no sustituido con la condición de que Ra y R3 no pueden ser ambos H; con la condición de que Ra y R*, junto con los átomos a los que están unidos, se combinan opcionalmente para formar un anillo de heterocicloalquilo sustituido o no sustituido de 6 a 10 miembros; y con la condición de que cuando R3 es H, Ra no tiene una estructura que es seleccionada de: benciloxilo no sustituido, -OCH2COOH, metoxilo, etoxilo con la condición de que cuando Ra es H, R3 no es ciano, o una sal hidrato o solvato del mismo. 2.- El compuesto según a reivindicación 1, que tiene una estructura según la fórmula siguiente:en la que C* es un átomo de carbono con la condición de que cuando R3 no es H, C* es un estereoisómero que tiene una configuración que es seleccionado de (R) y (S).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US94529407P | 2007-06-20 | 2007-06-20 | |
US4117808P | 2008-03-31 | 2008-03-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6251209A2 true CO6251209A2 (es) | 2011-02-21 |
Family
ID=40156702
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO09145296A CO6251209A2 (es) | 2007-06-20 | 2009-12-18 | Esteres ciclicos de boro y composiciones que los contienen |
Country Status (29)
Country | Link |
---|---|
US (4) | US7816344B2 (es) |
EP (1) | EP2164331B1 (es) |
JP (3) | JP5530923B2 (es) |
KR (3) | KR101578351B1 (es) |
CN (2) | CN101772302B (es) |
AR (1) | AR067105A1 (es) |
AU (1) | AU2008265630B2 (es) |
BR (1) | BRPI0813450B8 (es) |
CA (1) | CA2692135C (es) |
CL (1) | CL2008001855A1 (es) |
CO (1) | CO6251209A2 (es) |
CR (1) | CR11224A (es) |
DK (1) | DK2164331T3 (es) |
DO (1) | DOP2009000281A (es) |
EA (1) | EA020530B1 (es) |
ES (1) | ES2655299T3 (es) |
IL (1) | IL202379A (es) |
JO (1) | JO3396B1 (es) |
MA (1) | MA31675B1 (es) |
MX (1) | MX347688B (es) |
MY (1) | MY162692A (es) |
NO (1) | NO2164331T3 (es) |
NZ (1) | NZ582706A (es) |
PE (1) | PE20090840A1 (es) |
SG (1) | SG182219A1 (es) |
TW (1) | TW200911822A (es) |
UY (1) | UY31171A1 (es) |
WO (1) | WO2008157726A1 (es) |
ZA (2) | ZA200909003B (es) |
Families Citing this family (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI2343304T1 (sl) | 2005-02-16 | 2015-08-31 | Anacor Pharmaceuticals, Inc. | Biocidne boroftalidne spojine |
EP1976536A4 (en) * | 2005-12-30 | 2011-03-02 | Anacor Pharmaceuticals Inc | SMALL MOLECULES CONTAINING BORON |
CN101420854B (zh) | 2006-02-16 | 2013-08-07 | 安纳考尔医药公司 | 作为抗炎药的含硼的小分子 |
WO2007131072A2 (en) | 2006-05-02 | 2007-11-15 | Anacor Pharmaceuticals, Inc. | Hydrolytically-resistant boron-containing therapeutics and methods of use |
JO3396B1 (ar) * | 2007-06-20 | 2019-10-20 | Anacor Pharmaceuticals Inc | جزيئات صغيرة تحتوي على البورون |
RU2015109165A (ru) | 2008-03-06 | 2015-11-10 | Анакор Фармасьютикалз, Инк. | Борсодержащие малые молекулы в качестве противовоспалительных агентов |
WO2009140309A2 (en) * | 2008-05-12 | 2009-11-19 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
US8461336B2 (en) | 2008-09-04 | 2013-06-11 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
EP2348863A4 (en) | 2008-09-04 | 2012-03-07 | Anacor Pharmaceuticals Inc | BORN SMALL MOLECULES |
US9493489B2 (en) | 2008-10-15 | 2016-11-15 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as anti-protozoal agents |
US8461364B2 (en) * | 2008-12-17 | 2013-06-11 | Glaxosmithkline Llc | Polymorphs of (S)-3-aminomethyl-7-(3-hydroxy-propoxy)-3H-benzo[C][1,2]oxaborol-1-OL |
WO2010132833A1 (en) * | 2009-05-14 | 2010-11-18 | The Regents Of The University Of Michigan | Streptococcus vaccine compositions and methods of using the same |
RU2012107163A (ru) | 2009-07-28 | 2013-09-10 | Анакор Фармасьютикалз, Инк. | Тризамещенные борсодержащие молекулы |
WO2011019612A1 (en) | 2009-08-14 | 2011-02-17 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as antiprotozoal agents |
WO2011019616A1 (en) | 2009-08-14 | 2011-02-17 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as antiprotozoal agents |
AP4039A (en) | 2009-08-14 | 2017-02-28 | Daitao Chen | Boron-containing small molecules as antiprotozoal agents |
US20110207701A1 (en) * | 2009-08-19 | 2011-08-25 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as antiprotozoal agents |
WO2011037731A1 (en) * | 2009-09-25 | 2011-03-31 | Anacor Pharmaceuticals, Inc. | Boron containing small molecules |
US8979820B2 (en) | 2009-10-09 | 2015-03-17 | Cynthia S. Bailey | Method and apparatus for improving the appearance of nails affected by onychomycosis through the topical application of an aqueous solution containing boric acid and camphor or other terpenes |
US9346834B2 (en) | 2009-10-20 | 2016-05-24 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as antiprotozoal agents |
US8461134B2 (en) * | 2009-11-11 | 2013-06-11 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
WO2011094450A1 (en) | 2010-01-27 | 2011-08-04 | Anacor Pharmaceuticals, Inc | Boron-containing small molecules |
AP2012006482A0 (en) | 2010-03-19 | 2012-10-31 | Anacor Pharmacueticals Inc | Boron-containing small molecules as anti-protozoalagent |
CA2794684C (en) * | 2010-04-07 | 2018-04-24 | Glaxosmithkline Llc | Process for preparing benzoxaboroles |
SG10201507032YA (en) * | 2010-09-07 | 2015-10-29 | Anacor Pharmaceuticals Inc | Benzoxaborole derivatives for treating bacterial infections |
WO2013025975A1 (en) * | 2011-08-17 | 2013-02-21 | Glaxosmithkline Llc | Combination treatments for hepatitis c |
US9162999B2 (en) | 2011-09-28 | 2015-10-20 | Wisconsin Alumni Research Foundation | Catalytic conversion of cellulose to fuels and chemicals using boronic acids |
AR088669A1 (es) | 2011-11-21 | 2014-06-25 | Lilly Co Eli | Derivados de dihidrodibenzo[c][1,2]oxaborol y dihidroisoxazol utiles para el control de ectoparasitos |
AR088668A1 (es) | 2011-11-21 | 2014-06-25 | Lilly Co Eli | Moleculas pequeñas que contienen boro |
WO2013093615A1 (en) | 2011-12-22 | 2013-06-27 | Micurx Pharmaceuticals, Inc. | Tricyclic boron compounds for antimicrobial therapy |
US20150080342A1 (en) * | 2012-04-14 | 2015-03-19 | Anacor Pharmaceuticals, Inc. | Benzoxaborole compounds and uses thereof |
US10070649B2 (en) | 2013-01-30 | 2018-09-11 | Agrofresh Inc. | Volatile applications against pathogens |
US8669207B1 (en) | 2013-01-30 | 2014-03-11 | Dow Agrosciences, Llc. | Compounds and compositions |
US9585396B2 (en) | 2013-01-30 | 2017-03-07 | Agrofresh Inc. | Volatile applications against pathogens |
US11039617B2 (en) | 2013-01-30 | 2021-06-22 | Agrofresh Inc. | Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness |
AR094666A1 (es) | 2013-01-30 | 2015-08-19 | Dow Agrosciences Llc | Uso de benzoxaborolas como agentes antimicrobianos volátiles en carnes, plantas o partes de plantas |
US9446131B2 (en) | 2013-01-31 | 2016-09-20 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
US9452173B2 (en) | 2013-01-31 | 2016-09-27 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
US9433680B2 (en) | 2013-01-31 | 2016-09-06 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
US8778365B1 (en) | 2013-01-31 | 2014-07-15 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
WO2014121124A1 (en) | 2013-02-01 | 2014-08-07 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as antiprotozoal agents |
AU2014202928B1 (en) * | 2013-06-05 | 2014-09-11 | Agrofresh Inc. | Compounds and compositions |
KR101636431B1 (ko) | 2013-07-30 | 2016-07-05 | 동아에스티 주식회사 | 트리사이클릭 벤즈옥사보롤 화합물, 이의 제조방법 및 용도 |
DK3030519T3 (da) | 2013-08-09 | 2022-01-31 | Glaxosmithkline Ip No 2 Ltd | Tricykliske benzoxaborol-forbindelser og anvendelser deraf |
EA038093B1 (ru) * | 2013-12-20 | 2021-07-05 | Глаксосмитклайн Интеллекчуал Проперти (№2) Лимитед | Способ лечения заболевания, вызванного инфекцией комплекса mycobacterium tuberculosis, с использованием (s)-(3-хлор-7,8-дигидро-2h-1,6,9-триокса-9a-борабензо[cd]азулен-2-ил)метанамина или его фармацевтически приемлемой соли |
UY36000A (es) * | 2014-02-17 | 2015-09-30 | Syngenta Participations Ag | ?compuestos microbicidas, método para controlar o prevenir la infestación de microorganismos fitopa togenos, y composición de los mismos?. |
KR20170024068A (ko) * | 2014-07-01 | 2017-03-06 | 다이이찌 산쿄 가부시키가이샤 | 항박테리아제로서의 삼환식 벤즈옥사보롤 |
EP3212196A4 (en) * | 2014-10-29 | 2018-07-11 | Wisconsin Alumni Research Foundation | Boronic acid inhibitors of hiv protease |
MA41494B1 (fr) | 2015-02-12 | 2020-10-28 | Glaxosmithkline Ip No 2 Ltd | Composés benzoxaborole substitués en position 4 et utilisations associées |
EP3280262B1 (en) | 2015-04-09 | 2022-07-06 | The Penn State Research Foundation | Synergistic benzoxaborole-containing anti-fungicidal composition |
CA3014757C (en) * | 2015-08-06 | 2020-01-14 | The Penn State Research Foundation | Benzoxaborole-containing coating resistant to cellulose-supportable fungus |
CN113845536A (zh) | 2016-03-02 | 2021-12-28 | 比尔及梅琳达盖茨基金会 | 含硼小分子 |
US10874679B2 (en) | 2016-03-02 | 2020-12-29 | Bill & Melinda Gates Foundation | Boron-containing small molecules |
WO2017151489A1 (en) | 2016-03-02 | 2017-09-08 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
RS64770B1 (sr) | 2016-03-07 | 2023-11-30 | Agrofresh Inc | Sinergistički postupci upotrebe jedinjenja benzoksaborola i gasova za prezerviranje kao antimikrobnih agenasa za useve |
AU2017263785B2 (en) | 2016-05-12 | 2019-10-03 | Anacor Pharmaceuticals, Inc. | Oxaborole esters and uses thereof |
US10961261B2 (en) | 2017-03-01 | 2021-03-30 | Anacor Pharmaceuticals, Inc. | Oxaborole analogs and uses thereof |
CN107090000B (zh) * | 2017-04-27 | 2019-07-12 | 上海交通大学 | 一种苯并硼唑7位脂肪酸的衍生物及其制备与用途 |
US11944435B2 (en) | 2017-06-13 | 2024-04-02 | Vdi Laboratory, Llc | System and procedure for stabilizing, storing and recovering blood samples |
US11834466B2 (en) | 2017-11-30 | 2023-12-05 | 5Metis, Inc. | Benzoxaborole compounds and formulations thereof |
CA3120974A1 (en) * | 2017-11-30 | 2019-06-06 | Boragen, Inc. | Combinatorial compositions of benzoxaboroles and biologic agents |
CN112867494A (zh) | 2018-08-18 | 2021-05-28 | 博瑞金股份有限公司 | 取代苯并氧杂硼杂环戊烯的固体形式和其组合物 |
WO2020051575A1 (en) * | 2018-09-07 | 2020-03-12 | Boragen, Inc. | Boron containing compounds and their uses |
US11058695B2 (en) * | 2019-11-08 | 2021-07-13 | Myongji University Industry And Academia Cooperation Foundation | Inhibitor of carbapenem-hydrolyzing class D beta-lactamases |
EP4204012A1 (en) | 2020-08-31 | 2023-07-05 | Pfizer Inc. | Methods of protecting rna |
WO2023246842A1 (en) * | 2022-06-23 | 2023-12-28 | Shanghai Micurx Pharmaceutical Co., Ltd. | Prodrugs of boron compounds and their use in treating bacterial infections |
WO2023246841A1 (en) * | 2022-06-23 | 2023-12-28 | Shanghai Micurx Pharmaceutical Co., Ltd. | Methods and uses of boron compounds in the treatment of nontuberculous mycobacterium infections and pharmaceutical compositions for treatment of same |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2260336A (en) * | 1939-10-16 | 1941-10-28 | Dow Chemical Co | Method of preparation of organic borates |
GB1396904A (en) * | 1972-08-11 | 1975-06-11 | Ici Ltd | Method for the control of micro-organisms |
US5962498A (en) * | 1986-06-11 | 1999-10-05 | Procyon Pharmaceuticals, Inc. | Protein kinase C modulators. C. indolactam structural-types with anti-inflammatory activity |
US4919934A (en) | 1989-03-02 | 1990-04-24 | Richardson-Vicks Inc. | Cosmetic sticks |
US5594151A (en) * | 1994-01-28 | 1997-01-14 | Prolinx, Inc. | Phenylboronic acid complexing reagents derived from aminosalicylic acid |
GB9411587D0 (en) * | 1994-06-09 | 1994-08-03 | Zeneca Ltd | Compound, composition and use |
US6083903A (en) * | 1994-10-28 | 2000-07-04 | Leukosite, Inc. | Boronic ester and acid compounds, synthesis and uses |
US5831046A (en) * | 1996-08-05 | 1998-11-03 | Prolinx, Incorporated | Boronic acid-contaning nucleic acid monomers |
US6306628B1 (en) * | 1999-08-25 | 2001-10-23 | Ambergen, Incorporated | Methods for the detection, analysis and isolation of Nascent proteins |
AU7995300A (en) * | 1999-10-05 | 2001-05-10 | Bethesda Pharmaceuticals, Inc. | Dithiolane derivatives |
AU2001275930B2 (en) * | 2000-07-14 | 2007-05-10 | Eisai Inc. | Alpha-msh related compounds and methods of use |
US6537733B2 (en) * | 2001-02-23 | 2003-03-25 | Applied Materials, Inc. | Method of depositing low dielectric constant silicon carbide layers |
GB0117645D0 (en) * | 2001-07-19 | 2001-09-12 | Isis Innovation | Therapeutic stratergies for prevention and treatment of alzheimers disease |
DE10143979A1 (de) | 2001-09-07 | 2003-03-27 | Clariant Gmbh | Verfahren zur Herstellung von Bisallylboranen und nicht-aromatischen Boronsäuren |
WO2003033002A1 (fr) * | 2001-10-11 | 2003-04-24 | Ono Pharmaceutical Co | Inhibiteurs de l'augmentation de la concentration du calcium intracellulaire |
CA2473238A1 (en) | 2002-01-10 | 2003-07-24 | The Penn State Research Foundation | Methods for the preparation of alkyl diaryl borinates and complexed diarylboronic acids |
MX249034B (es) * | 2002-05-28 | 2007-09-14 | Dimensional Pharm Inc | Amidinas de tiofeno novedosas, composiciones de las mismas, y metodos para tratar enfermedades y condiciones mediadas por el complemento. |
EP1638578A4 (en) * | 2003-06-16 | 2009-04-01 | Anacor Pharmaceuticals Inc | BORON-CONTAINING THERAPEUTIC AGENTS WITH HYDROLYTIC RESISTANCE AND METHODS OF USE THEREOF |
PT1755661E (pt) * | 2004-05-12 | 2014-06-03 | Brigham & Womens Hospital | A utilização de gelsolina para o tratamento de infeções |
SI2343304T1 (sl) | 2005-02-16 | 2015-08-31 | Anacor Pharmaceuticals, Inc. | Biocidne boroftalidne spojine |
EP1976536A4 (en) * | 2005-12-30 | 2011-03-02 | Anacor Pharmaceuticals Inc | SMALL MOLECULES CONTAINING BORON |
CN101420854B (zh) * | 2006-02-16 | 2013-08-07 | 安纳考尔医药公司 | 作为抗炎药的含硼的小分子 |
US20070286822A1 (en) * | 2006-06-12 | 2007-12-13 | Anacor Pharmaceuticals Inc. | Compounds for the Treatment of Periodontal Disease |
CA2654449A1 (en) * | 2006-06-12 | 2007-12-21 | Anacor Pharmaceuticals, Inc. | Compounds for the treatment of periodontal disease |
DE102006038471A1 (de) | 2006-08-17 | 2008-04-10 | Wala-Heilmittel Gmbh | Platanencreme, Verfahren zu ihrer Herstellung und Verwendung |
JO3396B1 (ar) * | 2007-06-20 | 2019-10-20 | Anacor Pharmaceuticals Inc | جزيئات صغيرة تحتوي على البورون |
WO2009140309A2 (en) * | 2008-05-12 | 2009-11-19 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
-
2008
- 2008-06-18 JO JOP/2008/0288A patent/JO3396B1/ar active
- 2008-06-19 KR KR1020107001062A patent/KR101578351B1/ko active IP Right Grant
- 2008-06-19 US US12/142,692 patent/US7816344B2/en active Active
- 2008-06-19 MY MYPI20095460A patent/MY162692A/en unknown
- 2008-06-19 NO NO08825921A patent/NO2164331T3/no unknown
- 2008-06-19 MX MX2015007480A patent/MX347688B/es unknown
- 2008-06-19 SG SG2012045712A patent/SG182219A1/en unknown
- 2008-06-19 CN CN200880101464.4A patent/CN101772302B/zh active Active
- 2008-06-19 AU AU2008265630A patent/AU2008265630B2/en active Active
- 2008-06-19 WO PCT/US2008/067550 patent/WO2008157726A1/en active Application Filing
- 2008-06-19 EA EA200901617A patent/EA020530B1/ru not_active IP Right Cessation
- 2008-06-19 CA CA2692135A patent/CA2692135C/en active Active
- 2008-06-19 KR KR1020167009966A patent/KR101685656B1/ko active IP Right Grant
- 2008-06-19 NZ NZ582706A patent/NZ582706A/en unknown
- 2008-06-19 EP EP08825921.3A patent/EP2164331B1/en active Active
- 2008-06-19 DK DK08825921.3T patent/DK2164331T3/da active
- 2008-06-19 CN CN201410134063.6A patent/CN104017008A/zh active Pending
- 2008-06-19 BR BRPI0813450A patent/BRPI0813450B8/pt active IP Right Grant
- 2008-06-19 KR KR1020157021997A patent/KR20150100945A/ko not_active IP Right Cessation
- 2008-06-19 ES ES08825921.3T patent/ES2655299T3/es active Active
- 2008-06-19 JP JP2010513416A patent/JP5530923B2/ja active Active
- 2008-06-20 TW TW097123257A patent/TW200911822A/zh unknown
- 2008-06-20 UY UY31171A patent/UY31171A1/es unknown
- 2008-06-20 AR ARP080102661A patent/AR067105A1/es active IP Right Grant
- 2008-06-20 PE PE2008001074A patent/PE20090840A1/es not_active Application Discontinuation
- 2008-06-20 CL CL2008001855A patent/CL2008001855A1/es unknown
-
2009
- 2009-11-26 IL IL202379A patent/IL202379A/en active IP Right Grant
- 2009-12-11 DO DO2009000281A patent/DOP2009000281A/es unknown
- 2009-12-17 ZA ZA2009/09003A patent/ZA200909003B/en unknown
- 2009-12-18 CO CO09145296A patent/CO6251209A2/es not_active Application Discontinuation
-
2010
- 2010-01-15 MA MA32517A patent/MA31675B1/fr unknown
- 2010-01-18 CR CR11224A patent/CR11224A/es unknown
- 2010-07-30 US US12/848,051 patent/US8895534B2/en active Active
-
2011
- 2011-06-21 ZA ZA2011/04573A patent/ZA201104573B/en unknown
-
2014
- 2014-04-21 JP JP2014087397A patent/JP2014148531A/ja active Pending
- 2014-11-07 US US14/536,483 patent/US9796735B2/en active Active
-
2015
- 2015-09-24 JP JP2015187239A patent/JP6570391B2/ja active Active
-
2017
- 2017-09-28 US US15/718,422 patent/US10533021B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6251209A2 (es) | Esteres ciclicos de boro y composiciones que los contienen | |
UY28877A1 (es) | Compuestos de metil-aril o heteroaril-amida sustituida y composiciones | |
PE20170247A1 (es) | Derivados de pirrolidina-2,5-diona, composiciones farmaceuticas y metodos para usar como inhibidores ido1 | |
PE20181045A1 (es) | Compuestos utiles como inmunomoduladores | |
ES2477940T3 (es) | Imidazoles condensados y composiciones que los incluyen para el tratamiento de enfermedades parasitarias tales como por ejemplo malaria | |
PE20040450A1 (es) | Heteroariloxi-aril-espiro-pirimidina-2,4,6-triona n-sustituida como inhibidores de metaloproteinasa | |
CL2008001669A1 (es) | Compuestos derivados de piperidina/piperazina inhibidora de dgat-1; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso en el tratamiento de la obesidad, dislipidemia, fibrosis hepatica y diabetes tipo ii, entre otras. | |
UY28878A1 (es) | Compuestos de aril-o heteroarilamida ortosustituidos y composiciones | |
AR057855A1 (es) | Derivados de pirazina y composicion farmaceutica | |
EA201001682A1 (ru) | Производные фенил- и бензодиоксинилзамещенных индазолов | |
AR066881A1 (es) | Derivados de oxadiazol, una composicion farmaceutica que los comprende y su uso en la preparacion de medicamentos para el tratamiento de trastornos asociados con la disfuncion del glutamato. | |
SV2008003045A (es) | Aminotetrahidropiranos como inhibidores de dipertidil, peptidasa-iv para el tratamiento o prevencion de diabetes | |
AR091858A1 (es) | INHIBIDORES DE CISTATIONIN-g-LIASA (CSE) | |
AR071833A1 (es) | Inhibidores de quinasas (limk2), composiciones que los comprenden y metodos para tratar o prevenir enfermedades | |
PT2421879E (pt) | Novos 7-deazapurina nucleósidos para utilizações terapêuticas | |
AR091156A1 (es) | Nucleosidos de espirooxetano de uracilo | |
AR069490A1 (es) | Agonistas de los receptores de glucocorticoides | |
AR066882A1 (es) | Derivados de oxadiazol, una composicion farmaceutica que los comprende y su uso en la preparacion de medicamentos para el tratamiento de trastornos asociados con la disfuncion del glutamato. | |
CO6230986A2 (es) | Compuesto de 4-piridinona y su uso para cancer | |
MX2012002031A (es) | Moleculas pequeñas que contienen boro como agentes antiprotozoarios. | |
ECSP088965A (es) | Derivados de 2-tioxantina que actúan como inhibidores de la mpo | |
AR085327A1 (es) | Inhibidores del virus de la hepatitis c | |
NI200800008A (es) | Métodos para la neuroprotección | |
ECSP088457A (es) | Compuestos de benzamida útiles como inhibidores de la histona deacetilasa | |
ECSP077402A (es) | Derivados de 2-amido-4-feniltiazol, su preparación y su aplicación en terapéutica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Application refused |